Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Kintor Pharma Announces First Patient Dosing in Phase II Clinical Trial of KX-826 for Treatment of Androgenic Alopecia Patients in the US 2022-03-01 20:30
Zepp Health Corp. to Report Fourth Quarter and Full Year 2021 Financial Results on March 17, 2022 2022-03-01 19:30
PHASE II CLINICAL STUDY AT WEILL CORNELL MEDICAL CENTER INVESTIGATING PAXALISIB IN COMBINATION WITH METFORMIN AND A KETOGENIC DIET ENROLLS FIRST PATIENT 2022-02-28 21:00
First patient treated in cohort 2 SARTATE™ neuroblastoma therapy trial 2022-02-25 22:04
Terumo and Corazon Sign Collaboration and Co-Marketing Agreement 2022-02-25 22:00
Daewoong Pharmaceutical Announces Successful Phase 3 Topline Results for New Antidiabetic Drug's Triple Combination Therapy 2022-02-25 22:00
PharmAbcine Announces Last Patient Last Visit in its Phase Ib mTNBC Combination Trial 2022-02-25 21:00
HitGen has successfully completed a three-year collaboration with MTPC to discover novel hit compounds for multiple drug targets 2022-02-25 10:00
SeekIn Receives CE Mark Approval for SeekInCare® Pan Cancer Early Detection Test 2022-02-24 21:34
Primary endpoint met in Phase III clinical trial of Trilaciclib in Chinese patients with small cell lung cancer 2022-02-24 13:34
Jacobio JAB-21822 in Combination with Cetuximab Completes First Dose of Colorectal Cancer Patient in China 2022-02-24 10:32
Foresee Pharmaceuticals and TRPharm Announce License and Co-Development Agreement 2022-02-23 23:00
SyMap Medical Ltd Completed Enrollment in SMART Study for the Treatment of Uncontrolled Hypertension 2022-02-23 21:00
Simcere Pharma (2096.HK) Announces a Positive Profit Alert 2022-02-23 16:22
BIORCHESTRA Announces 45 Million USD Series C Fundraising 2022-02-23 11:26
Everise Names Kevin Bottoms as Chief Revenue Officer 2022-02-22 22:05
SPARK™ CLEAR ALIGNERS NEW RELEASE 12 GIVES DOCTORS MORE CONTROL, FLEXIBILITY AND EFFICIENCY IN CASE SETUP AND TREATMENT PLANNING 2022-02-22 22:00
Gracell Biotechnologies Announces Multiple Advancements of TruUCAR Allogeneic CAR-T Platform 2022-02-22 20:30
InnoCare Announces Dosing of First Patient in Phase II Clinical Trial Using Orelabrutinib for the Treatment of ITP 2022-02-22 17:09
111 to Announce Fourth Quarter and Fiscal Year 2021 Unaudited Financial Results on March 17, 2022 - Conference Call to Follow 2022-02-22 16:38
1 172 173 174 175 176 801